Please login to the form below

Not currently logged in
Email:
Password:

stem cells

This page shows the latest stem cells news and features for those working in and with pharma, biotech and healthcare.

Another R&D flop for Incyte, but Jakafi keeps delivering

Another R&D flop for Incyte, but Jakafi keeps delivering

GVHD occurs when donated bone marrow or peripheral stem cells mount an immune response to the recipient, and is a serious and life-threatening condition with first-year mortality of between

Latest news

More from news
Approximately 6 fully matching, plus 94 partially matching documents found.

Latest Intelligence

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    As well as being head of a programme in Cambridge, Sarah also chairs a hugely ambitious project to map all the cells in the human body, known as the Human Cell ... Kathy Niakan is a group leader investigating the mechanisms of lineage specification in

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead asset, allogeneic expanded adipose-derived stem cells (eASC) locally administered for

  • Deal Watch December 2016 Deal Watch December 2016

    320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... the affinity and selectivity of antibodies with the properties of small molecules, Evotec's induced pluripotent stem cells

  • Deal Watch July 2016 Deal Watch July 2016

    It is a humanised inducible co-stimulator (ICOS) agonist antibody, designed to both stimulate T effector cells and selectively reduce intra-tumoural T regulatory cells. ... Acquisition. 416. TiGenix/ Takeda. Cx601 - Stem cell treatment for perianal

  • Deal Watch June 2016 Deal Watch June 2016

    domain. For XmAb14045 the tumour antigen binding domain is CD123 (highly expressed on AML cells and leukaemic stem cells) and for XmAb13676 the tumour antigen binding domain is CD20 (highly expressed ... on B-cell tumor cells, including chronic

More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics